Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Antibodies
Immunotherapy
Indications:
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 14
On the market: 1
Description:
BioArctic AB is a research-focused biopharmaceutical company developing therapies for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The company’s lead product, Leqembi (lecanemab), is indicated for early Alzheimer’s disease. In addition to Leqembi, BioArctic maintains a research portfolio of antibody-based therapies targeting Parkinson's disease and ALS as well as additional projects against Alzheimer's disease....
